Daewoong (003090.KS)
Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam, South Korea.
Company Info
Highlights
₩1.04T
₩1.97T
₩870.61B
₩14,905.98 - ₩27,831.10
₩28,000.00
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Daewoong (003090.KS) returned 17.36% year-to-date (YTD) and 55.88% over the past 12 months. Over the past 10 years, 003090.KS returned 8.04% annually, underperforming the S&P 500 benchmark at 10.85%.
003090.KS
17.36%
24.57%
21.02%
55.88%
-3.81%
8.43%
8.04%
^GSPC (Benchmark)
0.51%
3.96%
-2.00%
12.02%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of 003090.KS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -4.63% | -2.43% | -6.77% | 8.32% | 24.88% | 17.36% | |||||||
| 2024 | 12.35% | -5.17% | -8.18% | -6.83% | -12.75% | -6.21% | 39.61% | 19.30% | -8.38% | 10.43% | -18.50% | 3.11% | 5.61% |
| 2023 | 8.85% | -22.66% | -11.33% | -1.71% | -1.81% | -14.60% | 3.83% | 9.62% | 9.75% | -4.73% | 12.08% | 23.65% | 1.47% |
| 2022 | -21.26% | 23.31% | 3.65% | -3.84% | -3.83% | -5.71% | 3.67% | -14.16% | -13.61% | -1.43% | -1.69% | 0.73% | -34.15% |
| 2021 | -7.06% | -21.82% | -10.53% | 11.01% | 1.38% | 27.04% | -20.75% | -2.02% | -8.40% | -4.96% | -2.22% | 0.80% | -38.08% |
| 2020 | -11.58% | -11.35% | 10.34% | 55.36% | -0.86% | 57.68% | -5.88% | 39.65% | -13.85% | -23.70% | 9.15% | 96.52% | 289.24% |
| 2019 | 2.81% | 9.29% | -0.75% | 9.07% | -16.63% | -5.54% | -8.80% | 6.11% | -10.61% | -3.39% | -11.58% | 3.59% | -26.67% |
| 2018 | -0.26% | -3.89% | 13.75% | -11.85% | 8.87% | -12.10% | -17.42% | 26.19% | -2.96% | -22.78% | 19.78% | 7.54% | -7.46% |
| 2017 | -6.36% | 23.88% | 2.35% | 22.94% | 10.03% | -7.42% | 15.65% | -1.32% | -3.68% | 7.99% | 11.25% | 12.49% | 120.88% |
| 2016 | 12.72% | -9.09% | 13.79% | -10.76% | 3.90% | 3.43% | -1.42% | -12.50% | -3.85% | -16.19% | 5.91% | -4.39% | -21.28% |
| 2015 | -4.10% | 6.93% | 2.59% | 2.74% | 37.30% | 49.10% | -18.22% | -9.06% | -9.83% | -4.93% | -7.06% | -3.50% | 26.52% |
| 2014 | -0.75% | -1.51% | 1.53% | -1.76% | -1.15% | 2.98% | 1.39% | 0.99% | 9.35% | 15.41% | -2.53% | -8.71% | 14.12% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 76, 003090.KS is among the top 24% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Daewoong (003090.KS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Daewoong provided a 0.79% dividend yield over the last twelve months, with an annual payout of ₩200.00 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | ₩200.00 | ₩200.00 | ₩0.00 | ₩100.00 | ₩100.00 | ₩100.00 | ₩100.00 | ₩100.00 | ₩100.00 | ₩100.00 | ₩100.00 | ₩100.00 |
Dividend yield | 0.79% | 0.93% | 0.00% | 0.49% | 0.32% | 0.20% | 0.77% | 0.56% | 0.52% | 1.14% | 0.88% | 1.11% |
Monthly Dividends
The table displays the monthly dividend distributions for Daewoong. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | |||||||
| 2024 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩200.00 | ₩200.00 |
| 2023 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 |
| 2022 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩100.00 | ₩100.00 |
| 2021 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩100.00 | ₩100.00 |
| 2020 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩100.00 | ₩100.00 |
| 2019 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩100.00 | ₩100.00 |
| 2018 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩100.00 | ₩100.00 |
| 2017 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩100.00 | ₩100.00 |
| 2016 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩100.00 | ₩100.00 |
| 2015 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩100.00 | ₩100.00 |
| 2014 | ₩100.00 | ₩100.00 |
Dividend Yield & Payout
Dividend Yield
Daewoong has a dividend yield of 0.79%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
Daewoong has a payout ratio of 12.99%, which is below the market average. This means Daewoong returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Daewoong. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Daewoong was 84.98%, occurring on Jul 26, 2023. The portfolio has not yet recovered.
The current Daewoong drawdown is 66.73%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -84.98% | Dec 23, 2020 | 640 | Jul 26, 2023 | — | — | — |
| -80.64% | Apr 12, 2002 | 205 | Mar 17, 2003 | 657 | Nov 10, 2005 | 862 |
| -77.22% | Feb 21, 1997 | 390 | Sep 22, 1998 | 707 | Aug 22, 2001 | 1097 |
| -72.37% | Mar 3, 2008 | 180 | Nov 20, 2008 | 1208 | Sep 26, 2013 | 1388 |
| -71.68% | Apr 11, 2018 | 476 | Mar 19, 2020 | 52 | Jun 5, 2020 | 528 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Daewoong over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Daewoong, comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 5.8% positive surprise.
Valuation
The Valuation section provides an overview of how Daewoong is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for 003090.KS compared to other companies in the Drug Manufacturers - Specialty & Generic industry. 003090.KS currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 003090.KS relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 003090.KS has a P/S ratio of 0.5. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 003090.KS in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 003090.KS has a P/B value of 1.0. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |